Free Trial

Firms Up A Tad In Early Trade

JPY

USD/JPY advanced Monday after U.S. President Trump signed off on the coronavirus relief bill, with liquidity thinned out in the festive season. The news that U.S. Pres-elect Biden is planning to invoke the Defence Production Act to boost the production of Covid-19 jabs lent further support to risk appetite, sapping strength from JPY.

  • Monday saw Japanese off'ls confirm the detection of a case of the new coronavirus variant, first found in South Africa.
  • USD/JPY has edged lower in early trade, last deals -12 pips at Y103.70. Dec 17 low of Y102.88 provides the initial layer of support and a break here would open up the 1.00 projection of Oct 7 - Nov 6 downleg from Nov 11 high at Y102.75. Bulls need a clearance of Dec 21/28 highs of Y103.89/90 before taking aim at Dec 11 high of Y104.28.
  • Japanese economic calendar is empty into the year-end.

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.